Applied DNA to Debut Security Print Platform Solution Featuring Videojet 1860M CIJ Printer at INTERPHEX 2018

STONY BROOK, N.Y. April 10, 2018 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or “the Company”) will debut its security print platform solution featuring the Videojet 1860M continuous inkjet (CIJ) printer at INTERPHEX 2018 in Booth 3957 at the Jacob K. Javits Convention Center in New York City on April 17-19. “This comprehensive [...]

Applied DNA Signs Definitive Agreements with Colorcon for Molecular Tagging in the Pharmaceutical and Nutraceutical Markets

Includes Milestone Payments. Long-Term Licensing Royalties to be Paid to Applied DNA Following Sales. STONY BROOK, N.Y., April 5, 2018 – Applied DNA Sciences, Inc., (NASDAQ: APDN) (“Applied DNA” or the “Company,”) has signed a License and Cooperation Agreement and a related Supply Agreement (collectively known as the “Agreements”), effective March 31, 2018, with [...]

Applied DNA and Rosier Deliver SigNature®-Tagged Fertilizer to Turkey and Africa

New Order Helps Applied DNA to Secure International Fertilizer Supply Chains STONY BROOK, N.Y. and MOUSTIER, BE.  March 23, 2018 – Applied DNA Sciences, Inc., (NASDAQ: APDN) (“Applied DNA” or “the Company,” NASDAQ: APDN), announced that it has fulfilled an order for the Company’s SigNature® molecular tags to track granular fertilizer destined for delivery [...]

GHCL Launches “Rekoop” Featuring Applied DNA’s CertainT Platform for the First Line of Source-Verified Recycled Plastic Bedding Products

STONY BROOK N.Y., March 20, 2018 – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN) today announced its CertainT® platform, ensuring authenticity through the entire supply chain, is featured in global manufacturer of home textiles GHCL, Limited’s (listed on NSE and BSE) new brand of bedding products made from recycled plastic (rPET), Rekoop. [...]


STONY BROOK, N.Y., (February 28, 2018) – Applied DNA Sciences, Inc. (NASDAQ: APDN) today announced that Dr. James Hayward, president & CEO, is scheduled to present at the 30th Annual ROTH Capital Markets Conference in Dana Point, CA on Tuesday, March 13 at 7:30 p.m. ET / 4:30 p.m. PT. Dr. Hayward will also hold [...]

Applied DNA and American & Efird to Collaborate on New Anti-Counterfeiting Sewing Thread Platform

Brands and Manufacturers can be certain that their products are authentic STONY BROOK, N.Y., (February 27, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that it is collaborating with American & Efird, (A&E), one of the world’s leading manufacturers and distributors of industrial and consumer sewing thread, embroidery thread, [...]

ACG signs MoU with Applied DNA Sciences to Enhance Capsule Authentication and Traceability Technology for Pharmaceutical and Nutraceutical Industry

Collaboration to help thwart counterfeits with molecular tagging of capsules STONY BROOK, N.Y., (February 26, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), and ACG have signed a memorandum of understanding (MoU) that will allow ACG to utilize Applied DNA’s proven SigNature® molecular tagging and authentication technologies to develop molecularly-tagged empty [...]

Applied DNA Awarded Additional U.S. Patent on its fiberTyping® Cotton Genotyping Technology

New Patent Strengthens the Company’s Robust Cotton Genotyping and Traceability Patent Portfolio STONY BROOK, N.Y., (February 22, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), is pleased to announce the receipt of a Notice of Allowance for its U.S. Patent Application No. 14/191,947 (US 2014/0295423 A1) entitled Methods for Genetic [...]

Applied DNA Reports Fiscal First Quarter 2018 Financial Results

Company To Hold Conference Call and Webcast Today, Thursday, February 8, 2018 at 4:30 PM EST. 8 February 2018 STONY BROOK, N.Y. – February 8, 2018 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), announced financial results for the fiscal 2018 first quarter ended December 31, 2017. “We made significant progress [...]

Applied DNA and TheraCann International Conduct Successful Tagging and Testing Pilot of Legal Cannabis and Derivative-Products

STONY BROOK N.Y. (February 5th, 2018) – Applied DNA Sciences, Inc. (NASDAQ: APDN, “Applied DNA,” “the Company”) announced today that in conjunction with TheraCann International Benchmark Corporation, it has had early success in the tagging and authentication of legal cannabis and its derivatives in a laboratory pilot. The pilot demonstrated that after a single application [...]